Search Results - "Bertran de lis Bartolome, B"

4CPS-022 Adherence to evolocumab and its impact on LDL cholesterol reduction by Bertran de lis Bartolome, B, González Sevilla, M, Ferrari Piquero, JM

“…Background and ImportanceAccording to the latest recommendations, the need to achieve lower cholesterol levels has become more important. Therefore, the use of…”
Get full text

5PSQ-216 Implementation of a medication reconciliation programme as a patient safety strategy by Mañes Sevilla, M, Rubio-Cebrian, B, De La Cruz Conty, ML, Bertran De Lis Bartolome, B, Moriel-Sanchez, C

“…Background and importanceMedication errors (ME) are especially frequent in hospital emergency departments (ED). To minimise these ME, medication reconciliation…”
Get full text

4CPS-107 Impact of a tool in the electronic clinical history for the optimisation of biologic drugs in rheumatology by Mañes Sevilla, M, Gómez-Caballero, EP, Bertran De Lis-Bartolome, B, Soto Baselga, I, Moriel-Sánchez, C

“…Background and importanceDosing optimisation means therapeutic benefit with the lowest possible dose for each patient, improving patient adherence and reducing…”
Get full text

4CPS-219 Comparison of the number of parental nutrition prescriptions in 2020 during the COVID-19 pandemic with the same time period in 2019 by Sollano-Sancho, I, Bertran De Lis-Bartolome, B, San Miguel-Torvisco, P, Morona-Minguez, I, Gomez-Caballero, E, Solis-Olivares, J, Soto-Baselga, I, Rubio-Cebrian, B, Picazo-Sanchis, G, Moriel-Sanchez, C

“…Background and importanceThe pharmacy service (PS) is a cornerstone of the nutritional support of patients, especially those with special needs. For this…”
Get full text

6ER-014 Analysis of the evolution of interleukin-6 in COVID-19 patients after being treated with dexamethasone by Pousada Fonseca, AB, Morona Mínguez, I, Garrido Peño, N, Soto Baselga, I, Solís Olivares, J, Rubio Cebrián, B, Mateos Mateos, Y, Sollano Sancho, I, Bertrán De Lis Bartolomé, B, Seco Moro, N, Moriel Sanchez, C

“…Background and importanceLevels of interleukin-6 (IL-6) in patients with coronavirus disease 2019 (COVID-19) are particularly relevant before treatment with…”
Get full text